Tenkasi (previously Orbactiv)
oritavancin
Soft Tissue Infections
Skin Diseases, Bacterial
Date of authorisation:
Revision: 14
Last updated:
MedicineHumanAuthorised
EMEA-001270-PIP01-12-M05 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Infectious diseases
PIP number: P/0236/2022
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for concentrate for solution for infusion
Age-appropriate dosage form for parenteral use
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Ramvocid
oritavancin
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
Forcaltonin
recombinant salmon calcitonin
Hypercalcemia
Osteitis Deformans
Bone Resorption
Date of authorisation:
Last updated:
MedicineHumanWithdrawn